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Rationale: Patients with acute dyspnea are a large heterogeneous patient groupwhere initial management is im-
portant for outcome.
Objectives: The objective of the study is to investigate if venous blood gas parameters predict 1-year risk of read-
mission or death in patients admitted to the emergency department due to acute dyspnea.
Methods:We studied 283 patients with acute dyspnea and followed them up for 1 year regarding incidence of
readmission or death.
Measurements and main results: In venous blood obtained immediately upon admission levels of total carbon di-
oxide (TCO2), base excess (BE), potential hydrogen (pH), and partial pressure of carbon dioxide (pCO2) were
measured. In Cox proportional hazards models, patients belonging to top and bottom quartiles of TCO2, BE, pH,
and pCO2were compared to patients belonging to the 2 central quartiles and assessed for end point. After adjust-
ment, top (hazard ratio [HR], 1.48; 95% conﬁdence interval [CI], 1.08-2.04; P= .016) and bottom (HR, 1.54; 95%
CI, 1.08-2.18; P= .017) quartiles of BEwere associatedwith increased risk of readmission or death. The strongest
predictor was top quartile of TCO2 (HR, 1.68; 95% CI, 1.21-2.35; P= .002). In the combined analysis, top quartile
of TCO2 remained signiﬁcantly related to the end point (HR, 1.59; 95% CI, 1.03-2.45; P= .035), whereas BE be-
came nonsigniﬁcant. Comorbidities, for example, prevalent chronic obstructive pulmonary disease, did not ex-
plain the association. Neither pCO2 nor pH predicted the end point.
Conclusions:Ahighvalueof TCO2 appears tobe an easily accessiblemarker for 1-year readmissionordeath inpatients
with acute dyspnea andmay thus add clinically important information for risk stratiﬁcation and follow-up strategies.
© 2015 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Patients presenting with acute dyspnea at the emergency depart-
ment (ED) is a large andheterogeneous patient groupwith highmortal-
ity and readmission rates [1-8]. Initial ED management, level of care,
and follow-up strategies are important factors for the outcome of
acute dyspnea patients [9-12]. However, the individual prognosis is dif-
ﬁcult to accurately assess. The use of plasma biomarkers for improved
determination of prognosis in acute dyspnea has largely focused on pa-
tients with congestive heart failure and, to a lesser degree, on patients
with chronic obstructive pulmonary disease (COPD). Many biomarker
studies include markers of inﬂammation or cardiac stress [11,13-17],
whereas the value of blood gas parameters [18,19] and the role ofhe European Research Council
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. This is an open access article underbiomarkers in unselected patients with acute dyspnea on clinical out-
come have been poorly studied.
The underlying causes of dyspnea can be difﬁcult to assess in an
early setting. Risk stratiﬁcation of prognosis is central for clinical deci-
sions on the level of care, treatment intensity, and urgency of reaching
a deﬁnitive underlying diagnosis. Most plasma biomarkers in acute dys-
pnea used at the ED have diagnostic purposes (eg, troponin T and C-
reactive protein), whereas medical history and scores of vital parame-
ters are used to assess prognosis, level of care, and treatment intensity.
In Sweden, the “Medical Emergency Triage and Treatment System
Adult” (METTS-A) is a standard tool for risk assessment and triage of
ED patients and was used during the time of study enrollment [20].
In patients with COPD and acute dyspnea, a high pressure of carbon
dioxide in arterial blood is a well-established predictor of poor progno-
sis and motivates a high level of care and treatment intensity [8,21].
However, in the general setting of patients with acute dyspnea at the
ED, arterial blood gas analysis is usually not performed. Therefore, it
cannot be evaluated or used as a routine biomarker for risk stratiﬁca-
tion. Increasing evidence points toward that arterial and venous blood
gas results can be used interchangeably [18,19,22-24]. In the ED, venousthe CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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point-of-care equipment as arterial blood with immediate generation
of test results [25]. To our knowledge, venous carbon dioxide and
acid-base balance have never been evaluated as prognostic biomarkers
in unselected ED patients admitted because of acute dyspnea.
The aim of the study was to investigate if easily accessible venous
blood gas analysis of total carbon dioxide (TCO2), base excess (BE), po-
tential hydrogen (pH), and partial pressure of carbon dioxide (pCO2)
predicts 1-year risk of readmission or death in patients admitted to
the ED due to acute dyspnea.
2. Methods
We studied patients presenting with dyspnea during 2011 at the ED
of the University Hospital of Skåne in Malmö, Sweden. In 2011, the de-
partment had approximately 83000 visits. The hospital is the only
emergency hospital in the municipality of approximately 300000500 visits of patients presenting with acute 
dyspnea at the ED during 1st of January to 31st
December 2011were randomly selected for 
review of patient records.
469 visits were further assessed.
435 visits were further assessed.
427 visits were further assessed.
321 visits were further assessed
This yielded 283 patients with acute dyspnea
included in the study.
297 visits were further assessed.
Fig. 1. Selection of patientsinhabitants. The study was approved by the regional board of ethics in
Lund. All patients of 18 years of age or older presenting with acute dys-
pnea as the major complaint were eligible for the study. This yielded
5057 visits of patients with acute dyspnea of which 500 were randomly
selected for review of patient records. In total, 283 fulﬁlled study criteria
for inclusion in our analyses (Fig. 1). Data collection was performed in
2013 from themedical records of the University Hospital of Skåne. Var-
iables recorded included sex (male/female), age (years), vital signs and
symptoms according to METTS-A [20], pulse oximetry (percentages),
respiratory rate (RR, rate/min), pH (pH scale), BE (millimoles per liter)
[26,27], pCO2 (kilopascal), TCO2 (millimoles per liter), medical history,
and readmission or death within 1 year. In the METTS-A ED triage sys-
tem, patients with respiratory complaints are categorized into dyspnea,
chest pain, or hyperventilation and ranked into 4 priority levels accord-
ing to vital signs. Priority 4 comprises patients with normal vital signs;
and priority 1, patients with pathologic vital signs needing immediate
medical attention [20]. Additional detail on the methods for making31 visits were excluded due to 
and no occurrence of dyspnea.
34 visits were excluded as the patients left
the hospital before physical examination.
8 visits were excluded due to incomplete 
personal identity number and lacking 
medical records.
106 visits were excluded due to missing 
blood gas parameters.
14 patients were recurrent visitors and
excluded from statistical analysis after first 
readmission.
19 visits were excluded due to missing 
respiratory rate data and 5 visits were 
excluded due to missing pulsoximetry data.
for statistical analysis.
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bined end point was either a ﬁrst hospital readmission regardless of
cause or death during the 1-year follow-up period. Date of death was
registered from a regional or national population register. Planned re-
visits were not included.
Venous blood gas parameters were obtained upon arrival to the ED.
The blood gas samples were immediately analyzed on a Radiometer
ABL800 Flex (Copenhagen, Denmark) [25]. Among the parameters ana-
lyzed, TCO2 represents the total dissolved carbon dioxide in the blood
and is constituted to approximately 95% of bicarbonate (HCO3−) and
to 5% of carbon dioxide (CO2), and carbonic acid (H2CO3) [28].We relat-
ed the venous blood gas parameters with the risk of readmission or
death using Cox proportional hazard models. The following 3 adjust-
ments were used: In model 1, we adjusted for age and sex. In model 2,
we included additional adjustment for METTS-A. In model 3, we
added saturation, RR, and if statistically signiﬁcant acid base parameters.
Finally, we also adjusted model 3 for a history of COPD. Venous blood
gas parameters were divided into quartiles. The 2 central quartiles
were merged and deﬁned as the reference group and compared to the
top and bottom quartiles, respectively. Statistical analysis was per-
formed in IBM SPSS (Malmö, Sweden) Statistics version 21. P b .05
was considered signiﬁcant. Schoenfeld's test was performed to assure
validity of the proportional hazards. In the subset of the population
where both venous and arterial blood gas analyses were performed,
we correlated blood gas parameters using Spearman correlation analysis.
3. Results
A total of 283 patients with acute dyspnea at the ED were evaluated
(Fig. 1). The mean age was 66.1 years (66.1 ± 18.5 years), and females
(55.8%, 158/283)weremore common thanmales. Most patients admit-
ted for inpatient care was admitted to a general ward (39.9%, 113/283).
A large proportion of the patients were directly discharged from the ED
(36.7%, 104/283). The remainingwere either admitted to an emergency
ward (21.2%, 60/283) or an intensive care unit (2.1%, 6/283). During the
1-year follow-up, 74.2% (210/283) of the patients were readmitted or
died, of which 67.1% (190/283) had a ﬁrst readmission and 7.1% (20/
283) died with no prior readmission. Detailed patient characteristics
are shown in Table 1.
The bottom quartile of BE ranged from−26 to−1.0mmol/L; and the
top quartile, from 3.0 to 15 mmol/L. The bottom quartile of TCO2 rangedTable 1
Patient base line characteristics
Age (y), mean (±SD) 66.1 (±18.5)
Sex (male), n (%) 125 (44.2%)
Medical history, n (%)
COPD 70 (24.7%)
Congestive heart failure 58 (20.5%)
Pneumonia 27 (9.5%)
Myocardial infarction 14 (4.9%)
Pulmonary embolism 3 (1.1%)
Vital parameters, mean (±SD)
Oxygen saturation (%) 93.6 (±5.15)
RR (min−1) 23.5 (±6.57)
Heart rate (min−1) 93.5 (±20.9)
Systolic blood pressure (mm Hg) 146 (±26.2)
Diastolic blood pressure (mm Hg) 80.9 (±14.6)
Body temperature (°C) 37.2 (±0.78)
METTS-A category, n (%)
Priority 1 34 (12.0%)
Priority 2 72 (25.4%)
Priority 3 68 (24.0%)
Priority 4 109 (38.5%)
Venous blood gas parameters, mean (±SD)
BE (mmol/L) 1.31 (±3.23)
pH (pH scale) 7.40 (±0.06)
TCO2 (mmol/L) 27.3 (±3.73)
pCO2 (kPa) 5.80 (±1.23)from 4.0 to 24 mmol/L; and the top quartile, from 30 to 40 mmol/L. The
bottom quartile of pH ranged from a value of 7.07 to 7.36; and the top
quartile, from 7.44 to 7.59. The bottom quartile of pCO2 ranged from 2.9
to 5.0 kPa, and the top quartile from 6.5 to 13.5 kPa.
In Cox proportional hazardmodels adjusted for age and sex, top quar-
tile of BE (hazard ratio [HR], 1.56 [conﬁdence interval {CI}, 1.14-2.15]; P=
.006) and bottom quartile of BE (HR, 1.65 [CI, 1.17-2.32]; P= .004) were
strongly associatedwith the end point. In themultivariatemodels adjust-
ed for age, sex, METTS-A, saturation, and RR, both top quartile (HR, 1.48
[CI, 1.08-2.04]; P = .016) and bottom quartile (HR, 1.54 [CI 1.08-2.18];
P = .017) of BE were associated with increased risk of readmission or
death (Table 2). However, when adjusting for TCO2, there was no associ-
ation of top quartile BE with the end point (HR, 1.13 [CI, 0.75-1.71]; P=
.570), and the association of bottom quartile BE was no longer signiﬁcant
(HR, 1.63 [CI, 0.99-2.68]; P= .056).
When adjusting for age and sex, patients in the top quartile of TCO2
had an increased risk of readmission or death (HR, 1.93 [CI, 1.40-2.67];
P = .000). This association was also seen for bottom quartile of TCO2
(HR, 1.46 [CI, 1.02-2.07]; P= .037). After additional adjustment for age,
sex, METTS-A, saturation, and RR, top quartile but not bottom quartile of
TCO2 remained signiﬁcant (Table 2). Top quartile of TCO2 was signiﬁcant
in the multivariate model including BE (HR, 1.59 [CI, 1.03-2.45]; P =
.035). Top quartile of TCO2 also remained signiﬁcant after adjustment
for a history of COPD (HR, 1.61 [CI, 1.15-2.26]; P= .005) with a relative
risk increase greater than for prevalent COPD (HR, 1.50 [CI, 1.09-2.06];
P = .012). A Kaplan-Meier plot of TCO2 in relation to the end point
is shown in Fig. 2. In the patient group with top quartile levels of
TCO2, 33.8% (23/68) of the patients were discharged from the ED, 39.7%
(27/68) were admitted to a general ward, 22.1% (15/68) were admitted to
anemergencyward, and4.4% (3/68)wereadmitted to an intensive careunit.
Older age (HR, 1. 01 [CI, 1.01-1.02]; P= .002) and higher priority ac-
cording toMETTS-A (HR, 1.31 [CI, 1.07-1.61]; P=.008)were other factors
independently associated with the end point adjusted for BE and TCO2.
Neither pH nor pCO2 was associated with increased risk of readmission
or death (Table 2). In the subset of patients with both arterial and venous
blood gas parameters obtained, there was a good correlation of blood gas
parameters. In Spearman correlation analysis, venous pCO2 and pH were
strongly correlatedwith arterial pCO2 (n=43; rs= 0.763; P= .000) and
pH (n = 42; rs = 0.852; P= .000), respectively.
4. Discussion
For patients with acute dyspnea at the ED, TCO2 ranging from 30 to
40 mmol/L was a predictor of 1-year readmission and mortality. High
and low BE was also related to poor outcome. However, this prognostic
information was mediated by TCO2, as BE became nonsigniﬁcant in the
combined statistical analysis. Total carbon dioxide remained related to
the end point with an effect size stronger than for prior COPD.
Surprisingly, little is known about TCO2 in patients with dyspnea at
the ED, its prognostic value, and its impact on patient outcome. The
mechanisms causing dyspnea are still incompletely understood [1],
and the knowledge of which factors contribute to the blood concentra-
tion of TCO2 is largely based on experimental animal studies and theo-
retical conclusions [29-33].
In the steady state at the dissociation equilibrium, TCO2 is used as a
surrogate marker of bicarbonate. Both BE and TCO2 increase as a result
of metabolic alkalosis. The underlying causes to these shifts are many.
Possible explanations to metabolic alkalosis in the acutely dyspneic pa-
tient may be diuretic treatment, hypokalemia, or posthypercapnia [28].
Total carbon dioxide additionally increases in compensation to respira-
tory acidosis [28]. In this study, elevated BE did not associate with the
end point when adjusting for TCO2, although it may have correlated to
the end point with a larger study size. This suggests that elevated
TCO2 in the dyspneic patient is not caused by metabolic alkalosis. It
also suggests that the raised levels of TCO2 are not only a consequence
of increased bicarbonate levels.
Table 2
Cox proportional hazard models adjusted for age, sex, METTS-A, respiratory rate, and oxygen saturation
Model 3 Quartile 1 Quartiles 2 and 3 Quartile 4
No. events/N HR (95% CI) P No. of events/N HR (95% CI) P No. of events/N HR (95% CI) P
BE 56/71 1.535 (1.080-2.181) .016860 82/126 Reference 72/86 1.482 (1.075-2.043) .016418
TCO2 45/59 1.348 (0.942-1.930) NS 106/156 Reference 59/68 1.682 (1.205-2.349) .002270
pH 58/73 0.918 (0.507-1.663) NS 105/144 Reference 47/66 1.139 (0.633-2.051) NS
pCO2 47/71 0.903 (0.638-1.277) NS 109/147 Reference 54/65 1.196 (0.850-1.683) NS
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and poorer outcome in terms of readmissions and mortality tended to
have both elevated TCO2 and negative BE values. In the multivariate
analysis, elevated TCO2 remained signiﬁcant, but base deﬁcit became
borderline signiﬁcant. This ﬁnding can partly be explained by the pres-
ence of hypoventilated and metabolically compensated patients with
COPD. As BE is reduced by respiratory acidosis, this can also explain
the trend of base deﬁcit with increased rates of readmission andmortal-
ity. In comparison to BE that only quantiﬁes metabolic acid base disor-
ders, TCO2 is a marker of both respiratory and metabolic acid base
balance disorders [34,35] that, in this study, correlated to poorer out-
come. Therefore, we speculate that TCO2 in patients with acute dyspnea
is an indicator of uncompensated respiratory acidosis. Given this, TCO2
may be more suitable than BE for assessing acute dyspnea in the chron-
ically ill patients, as it involves both metabolic and respiratory compo-
nents. Total carbon dioxide may also be more suitable than venous
pCO2 in predicting outcome in the critically ill with history of COPD. It
is less transient in nature than the gas parameters and seems to be a bet-
ter marker for long-term outcome than venous pCO2 and venous pH
that showed no correlation to the end point.
In common conditions causing acute dyspnea such as COPD, pneu-
monia, ischemic heart disease, congestive heart failure, and pulmonary
embolism, deranged TCO2 levels can represent a transient or permanent
systemic impairment. As high TCO2 predicted poor outcome during as
much as 1 year after the acute episode of illness, it can stand for an
unmasked underlying cardiopulmonary fragility, which, in the long
term, associates with increased readmissions and mortality rates. In
the heterogeneous patient group with dyspnea, the diagnostics is chal-
lenging, and a correct early management is important for prognosis.
There are some biomarkers used for diagnostic and prognostic purposes
in dyspnea patients. These have been included in scores often together
with vital signs to predict poorer outcome [9-11], but at present, thereFig. 2. Cumulative end point curves for quartiles of totalis no separate blood biomarker for evaluation of prognosis and risk
stratiﬁcation of dyspnea patients. Traditionally, arterial blood gas analy-
sis has predominantly been used to evaluate blood gas and acid-base
disorders. In fact, in this and recent studies, there is a good correlation
of venous to arterial blood gas parameters (with the exception of pO2)
[19,22-24,36]. Easily accessible venous blood gas may thus be used in
the ED to add clinically important information in a broad patient
group with acute dyspnea without restricting the use of arterial blood
gas when indicated.
The causes of dyspnea, death, and readmission were not systemati-
cally registered, and the underlying conditions leading to the events re-
main unclear. However, the intention of the studywas to evaluate long-
term prognostic factors for all-cause readmission or death in unselected
patients with acute dyspnea. The knowledge of the actual underlying
conditions seems to be less important for this purpose. The diseases
causing dyspnea often coexist and share the same risk factors. A distinc-
tion between them is difﬁcult to accurately assess in the clinical setting.
Identiﬁcation of the prognostic factors for speciﬁc diagnoses in patients
with dyspnea was, therefore, not in the scope of this study. Apart from
having dyspnea as the main complaint, we intentionally applied no se-
lection criteria for the study population to maintain the heterogeneity
and aiming at making results applicable on a random dyspneic patient
seeking medical care. We do acknowledge that many patients were ex-
cluded due to missing blood gas parameters. A selection bias would de-
spite this probably have lead to enrichment of even more severely ill
patients. Most of the patients excluded were either relatively young pa-
tients not hospitalized or terminally ill patients where the ED physician
judged that prognostic and diagnostic efforts were unnecessary.
Given the easy accessibility, fast response time, low costs, and negli-
gible risks of a venous blood gas analysis, we ﬁnd our results encourag-
ing and potentially clinically applicable. Total carbon dioxide may help
deciding the level of care upon admission and determining the follow-carbon dioxide during the 1-year follow-up period.
1339N. Lund et al. / American Journal of Emergency Medicine 33 (2015) 1335–1339up strategies for out-of-hospital care in patients with acute dyspnea to
prevent readmissions and death. It should, however, be emphasized
that the sample size ismoderate and replications of our results in similar
patient cohorts are essential for clinical implementation.
In conclusion, a high level of TCO2 in patients with acute dyspnea is a
marker for worse outcome. This easily accessible blood gas parameter
may prove useful in the ED for risk stratiﬁcation of dyspnea patients.Author contributions
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